For Immediate Release:
|Contact:||Allen & Caron Inc||CLOSURE Medical Corp|
|Jay McKeage (investors)||Len Hall (media)||Benny Ward, CFO|
|(212) 691-8087||(949) 474-4300||(919) 876-7800|
RALEIGH, NC (June 1, 2004) … CLOSURE Medical Corporation (Nasdaq:CLSR), a global leader in biomaterial-based medical devices, is scheduled to present at the Pacific Growth Equities Life Sciences Growth Conference at the Mark Hopkins Inter-Continental Hotel in San Francisco on Thursday, June 10, 2004.
Daniel A. Pelak, President & CEO, will deliver the Company’s presentation beginning at approximately 11:00 a.m. EDT (8:00 a.m. PDT). A live audio webcast of the presentation will be available via a link provided under the Investor section of CLOSURE Medical’s website at www.closuremed.com. An archive of the presentation will be available for 14 days.
About CLOSURE Medical Corporation
CLOSURE Medical Corporation is a global leader in the development and manufacture of innovative biomaterial-based medical devices that fulfill the needs of healthcare practitioners, patients and consumers.
For additional information on CLOSURE Medical visit its website at www.closuremed.com or visit the “Clients” section of the Allen & Caron website at www.allencaron.com.
This release contains certain forward-looking statements
which involve known and unknown risks, delays, uncertainties or other factors
not under the Company's control which may cause actual results, performance
or achievements of the Company to be materially different from the results,
performance, or other expectations implied by these forward-looking statements.
These factors include, but are not limited to the early stage of commercialization
of the Company’s products; the progress of its research and development
programs for future products; the need for regulatory approval and effects of
governmental regulation; technological uncertainties; the satisfactory conclusion
of negotiations with, and dependence on marketing partners, and dependence on
patents and trade secrets, as well as those detailed in the Company's Annual
Report on Form 10-K for the year ended December 31, 2003, filed with the Securities
and Exchange Commission. Although the Company believes that the expectations
in the forward-looking statements are reasonable, the Company cannot guarantee
such results. The Company undertakes no obligation to publicly revise these
forward-looking statements to reflect events or circumstances that arise after
the date hereof.